Company News

Divine Skin To Create Consumer Health Care Unit

CEO Khesin calls move an “organic extension."

Author Image

By: TOM BRANNA

Editor

Divine Skin Inc.—maker of Spectral DNC, a Rogaine competitor—plans to launch a consumer health-care division to “capitalize on the pharmaceutical research it has conducted during the successful development of topical treatments for hair and skin.”

The Miami Beach, FL-based company said the new division will target both over-the-counter and prescription drug sectors.

In recent years, the company’s research into hair loss and other common skin conditions has resulted in high-performance topical solutions for men and women. These include effective therapies to restore growth and radiance to hair, suppress dandruff and unwanted hair, control acne, support feminine hygiene, and reduce the appearance of facial aging.

“Divine Skin brands have been built on a platform of technological innovation,” said founder and chief executive officer Daniel Khesin. “So innovative health care is an organic extension of the company’s principal activity.”

Last month Divine Skin announced a new agreement for its DS Laboratories brand to supply hair-growth products through Premier Salons, one of North America’s largest chains, with about 3,000 locations, many in prestigious department stores like Macy’s. The manufacturer estimates the deal to be worth $10.8 million per year once the entire retail chain is supplied.

Earlier in the year, Divine Skin announced a similar agreement with Fantastic Sams, a chain with approximatley 2,000 salons, anticipated to be worth $7.2 million per year when fully implemented.

Divine Skin said at its current rate, it expects to add 10,000 salon outlets during 2010. The company has been establishing sales and education teams based in California, Florida, New Jersey, and New York. Worldwide, Divine Skin distributes throughout the Americas (Canada, Mexico, Brazil), Europe (UK, France, Germany, Russia, Turkey) and Japan.

Keep Up With Our Content. Subscribe To Happi Newsletters